IL6 and COVID-19: We therefore performed candidate screening for biomarkers in serum that predict a change in IL-6 as a surrogate for COVID-19-associated inflammatory dysregulation by applying a machine-learning approach to serial blood measurements in five severe COVID-19 disease courses.